ClinVar Miner

Submissions for variant NM_001042413.2(GLIS3):c.2350G>C (p.Ala784Pro)

gnomAD frequency: 0.00001  dbSNP: rs754312328
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV001168439 SCV001331029 uncertain significance Neonatal diabetes mellitus with congenital hypothyroidism 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Fulgent Genetics, Fulgent Genetics RCV001168439 SCV002786529 uncertain significance Neonatal diabetes mellitus with congenital hypothyroidism 2022-02-03 criteria provided, single submitter clinical testing
Ambry Genetics RCV004032904 SCV004878142 uncertain significance Inborn genetic diseases 2023-10-16 criteria provided, single submitter clinical testing The c.1885G>C (p.A629P) alteration is located in exon 8 (coding exon 7) of the GLIS3 gene. This alteration results from a G to C substitution at nucleotide position 1885, causing the alanine (A) at amino acid position 629 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.